1-(2-(hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine,
2',3',5-FTC,
2',3'-dideoxy-5-fluoro-3'-thiacytidine,
2',3'-dideoxy-5-fluoro-3'-thiacytidine, (2S-cis)-isomer,
5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine,
524W91,
BW 524W91,
BW-524W91,
BW524W91,
Racivir,
ent-Emtricitabine,
137530-41-7,
Oxathiolan,
(+)-FTC,
5FC-(+)-beta,
UNII-9PDN1V466A,
9PDN1V466A,
(+)-(2S,5R)-5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine,
2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-,
4-amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one,
2',3'-Dideoxy-5-fluoro-3'-thiacytidine,
Emtricitabine, (+)-,
PSI 5004,
(+)-(2S,5R)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine,
2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-((2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-,
Racivir (TM),
5-FSddC,
Emtricitabine Enantiomer,
( )-2'-deoxy-5-flouro-3'-thiacytidine,
AC1L9RWY,
CHEMBL89554,
SCHEMBL267686,
ZINC5472,
CTK4C0856,
DLS-022,
4-Amino-5-fluoro-1-((2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one,
XQSPYNMVSIKCOC-RITPCOANSA-N,
5FC-(+).b.,
RCV,
(+/-)-FTC,
MFCD00870152,
AKOS027256113,
SC-89862,
(+)-2'-deoxy-5-flouro-3'-thiacytidine,
FT-0667849,
UNII-ULS8902U4O component XQSPYNMVSIKCOC-RITPCOANSA-N,
(+)-2 inverted exclamation mark -Deoxy-3 inverted exclamation mark -thia-5-fluorocytidine,
(2S-cis)-4-Amino-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone,
4-Amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone,
2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, rel- (+/-)-cis-1-(2-Hydroxymethyl)-1,3-oxathiolan-5-yl)-5-fluorocytosine,
Emtricitabine,
Racivir,
BW524W91,
BW 524W91,
BW-524W91,
CID454858,
2',3',5-FTC,
524W91,
C075889,
1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine,
2',3'-dideoxy-5-fluoro-3'-thiacytidine, (2S-cis)-isomer,
5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine,
143491-54-7,
FTC,